signs of leukemia in children

Leukemia in children



In children, leukemia, fatigue, weakness, low resistance, abdominal swelling, nose and gum bleeding, lymph gland growth can occur.
Leukemia in children


Professor Dr. Idil Yenicesu said that leukemia was the most common type of cancer in childhood in the context of the November 2-8 Leukemia Children's Week.

expressing that the parents can not understand these changes in their children because the symptoms of leukemia can be seen in many other childhood diseases, he stressed that this may lead to delay in the diagnosis.

WHEN DO CHILDREN WANT TO DO?

Because red blood cells that distribute oxygen to the body can not be produced in children with leukemia, the most common symptoms are fatigue and weakness. Dr. Yenicesu underlines that these children can not resist infection due to lack of healthy white blood cells.

Yenicesu pointed out that frequent bruising, nose and gingival hemorrhages occur because of the inability to produce blood platelets, and he continued: "In addition, bone pain often occurs due to the proliferation of leukemic cells in the bone, as the liver and spleen are also occupied by these cells, all lymph glands at 2 centimeters and above should be examined by a specialist doctor, because the red blood cells can not be produced in the sick children, and the skin color is faint, because it is due to the disease and because it is prone to infections during leukemia often accompanied by fever, which is accompanied by shortness of breath and unexplained weight loss. "

LEUKEMI SYMPOSIUM

Parents were warned that their children should be especially careful in case of fatigue, weakness, low resistance, abdominal bloating, nose and gingival bleeding, growth of lymph glands, unexplained weight loss, pain, paleness, fever and shortness of breath.
Afrin street street is memorized!

    share

Four breakthroughs in cancer treatment!
With magic bullets, success is up to 50 percent in the treatment, immunotherapy provides complete healing in some types of cancer, cancer that can not be treated due to intelligent molecules can be kept under control for years
Four breakthroughs in cancer treatment!

    News Health
    Thursday 01.02.2018 16:29

TARGETED TREATMENTS AND SMART MOLECULARS

While chemotherapy is now the only treatment option for many types of cancer, malignant tumors such as melanoma, kidney cancer and rare intestinal sarcoma that have not responded to chemotherapy can now be kept under control for many years thanks to intelligent molecules. On the other hand; there are effective methods and supportive medicines which decrease the side effects of chemotherapy, which cause serious side effects such as hair loss, mouth wounds, nausea and vomiting. With the ice cap method hair loss problem can be prevented. Unlike chemotherapy, targeted therapies target only genetic disorders in cancer cells because they are drugs that attack and destroy cancer cells. Professor Dr. Gökhan Demir says that targeted therapies are lung cancers, another cancer type that changes the treatment approach. Today, lung cancer is diagnosed by light microscopy immediately after the diagnosis of genes called EGFR, ALK, ROS are being investigated. If such a genetic disorder is detected, disease control can be achieved over 2 years with the intelligent molecules that started without giving chemotherapy. Second-generation third-generation molecules used in targeted therapies today can achieve 30-40 percent of the response even when the tumor develops resistance to treatment.



MAGIC MARBLES

The production of some molecules produced by the body's immune system against certain targets found in cancerous cells is another important step taken in recent years in oncology. These biological agents called 'magic bullets' are now being used effectively in lymph node cancers, breast cancers, colon cancer and head and neck cancers. When these magic bullets are added to conventional treatments, they increase the effectiveness of chemotherapy or radiotherapy by 30-50 percent.

IMMUNOTHERAPY

The ability of the body to use its own immune cells in the treatment of cancer, immunotherapy, is described as the biggest step taken in recent years in oncologic therapies. The immune cells, the basic protective cells of the body, have not been effective in cancer treatment for many years. The immune cells did not see the cancer cell as a foreign enemy cell. Combined with the suppressive effect of cancer treatments on the immune system, the immune system was totally disabled in combat with cancer. However, pioneering work in the melanoma, especially in the recent years with a particularly deadly skin cancer, has taught the medical world how the cancerous cell has deceived the immune system, hiding it. The new molecules produced in this light of information have enabled the immune cells to be effectively used in combat with cancer. With the new generation of immunotherapy drugs, melanoma, lung cancer, kidney and bladder cancer, head and neck cancers, stomach and intestinal cancers are achieved. Today, in some types of melanoma and lung cancers, complete healing can be achieved, even in advanced disease, simply by immunosuppressive immunotherapy without ever using chemotherapy treatment. Today, most of the cancer types, including breast cancer, ovarian cancer, brain cancer, are under investigation for immunotherapy treatment. In the near future, immunotherapy is indicated as a candidate for being a part of treatment for all types of cancer.

LIQUID BIOPSY

One of the areas of greatest development today is the new molecular methods that have been developed in cancer diagnosis and follow-up. Until today, the diagnosis of cancer was based on the principle that the tumor was shown radiologically and diagnosed with biopsies taken. However, in recent years, the liquid biopsy technique, which provides the isolation of the genetic material secreted from the cancerous cell and the molecular and genetic characterization of this material, is being shown as a breakthrough technique in the future of oncology. Professor of Medical Oncology Dr. Gökhan Demir says that with this technique cancer can be diagnosed even when it is too small to be shown radiologically in the future. One of the most important difficulties in cancer treatment is the concept of tumor heterogeneity. Dr. Gökhan Demir "This is a concept used to describe the genetic molecular changes that develop in the cancerous tissue in the process to resist the treatment of the end-stage cancer.When the clinical oncologists try to treat according to the characteristics of the biopsy material taken months or years ago, the enemy has already changed the genetic and molecular structure of the enemy "If the patient's recurring biopsies are robust, the changes in time in the genetic material of the tumorous cell from the patient's blood, and the arrangement of therapies according to these properties, constitute another giant step in the oncology."